CLINICAL STUDIES
Effect of age on outcome with primary angioplasty versus thrombolysis
David R. Holmes, Jr., MD, FACC*,
Harvey D. White, DSc, FACC ,
Karen S. Pieper, MS ,
Stephen G. Ellis, MD, FACC ,
Robert M. Califf, MD, FACC and
Eric J. Topol, MD, FACC
* Mayo Clinic and Foundation, Rochester, Minnesota, USA
Green Lane Hospital, Auckland, New Zealand
Duke Clinical Research Institute, Durham, North Carolina, USA
Cleveland Clinic Foundation, Cleveland, Ohio, USA
Manuscript received June 9, 1998;
revised manuscript received August 21, 1998,
accepted October 2, 1998.
Reprint requests and correspondence: David R. Holmes, Jr., MD, Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, Minnesota 55905
Objectives
The purpose of this study was to determine how risks associated with increasing age differed in patients treated with percutaneous transluminal coronary angioplasty versus thrombolysis.
Background
Advancing age is a risk factor for adverse outcome in patients with acute myocardial infarction. Primary angioplasty has been thought to be particularly beneficial in higher risk patients including the elderly. There is, however, limited data on any differential incremental benefit of angioplasty compared with thrombolysis in candidates for either treatment.
Methods
In the GUSTO-IIb angioplasty substudy, 1,138 patients were randomized to receive primary angioplasty or accelerated tissue-type plasminogen activator (t-PA). The effect of age on outcome was assessed as a discrete and continuous variable for each treatment group. Models using age as a linear factor as well as cubic spline transformations were used for the major end points of 30-day death or disabling stroke; death or reinfarction; and death, reinfarction or disabling stroke.
Results
For each 10-year patient group, outcome was improved with angioplasty (n = 565) compared with t-PA (n = 573). Irrespective of treatment, however, risk increased with age. After adjusting for baseline characteristics, each increment of 10 years of age increased the risk of death or myocardial infarction by 1.32 (95% confidence interval 1.04 to 1.76, p = 0.022). For all adverse outcomes, this incremental effect of increasing age was constant.
Conclusions
Advancing age is associated with worse outcomes, and the risks increase in proportion to age. Although primary angioplasty improves outcomes over thrombolysis, it does not appear to be more beneficial in older than in younger patient groups. The incremental adverse effect of age does not vary by treatment strategy.
|
Abbreviations and Acronyms
| | CI | = 95% confidence interval | | GUSTO-I | = Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesI | | GUSTO-II | = Global Use of Strategies to Open Occluded Coronary ArteriesII | | IV | = intravenous | | TIMI | = Thrombolysis in Myocardial Infarction | | t-PA | = tissue-type plasminogen activator |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. Singh, E. D. Peterson, M. T. Roe, F.-S. Ou, J. A. Spertus, J. S. Rumsfeld, H. V. Anderson, L. W. Klein, K. K.L. Ho, and D. R. Holmes
Trends in the Association Between Age and In-Hospital Mortality After Percutaneous Coronary Intervention: National Cardiovascular Data Registry Experience
Circ Cardiovasc Interv,
February 1, 2009;
2(1):
20 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Singh, E. D. Peterson, S. Milford-Beland, J. S. Rumsfeld, and J. A. Spertus
Validation of the Mayo Clinic Risk Score for In-Hospital Mortality After Percutaneous Coronary Interventions Using the National Cardiovascular Data Registry
Circ Cardiovasc Interv,
August 1, 2008;
1(1):
36 - 44.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Przyklenk, M. Maynard, C. E. Darling, and P. Whittaker
Aging Mouse Hearts Are Refractory to Infarct Size Reduction With Post-Conditioning
J. Am. Coll. Cardiol.,
April 8, 2008;
51(14):
1393 - 1398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol.,
August 14, 2007;
50(7):
e1 - e157.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
The PREAMI Investigators*
Effects of Angiotensin-Converting Enzyme Inhibition With Perindopril on Left Ventricular Remodeling and Clinical Outcome: Results of the Randomized Perindopril and Remodeling in Elderly With Acute Myocardial Infarction (PREAMI) Study.
Arch Intern Med,
March 27, 2006;
166(6):
659 - 666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Part 5: Acute Coronary Syndromes
Circulation,
November 29, 2005;
112(22_suppl):
III-55 - III-72.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. De Luca, A. W.J. van 't Hof, J. P. Ottervanger, J. C.A. Hoorntje, A.T. M. Gosselink, J.-H. E. Dambrink, M.-J. de Boer, and H. Suryapranata
Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty
Eur. Heart J.,
April 1, 2005;
26(7):
662 - 666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Guagliumi, G. W. Stone, D. A. Cox, T. Stuckey, J. E. Tcheng, M. Turco, G. Musumeci, J. J. Griffin, A. J. Lansky, R. Mehran, et al.
Outcome in Elderly Patients Undergoing Primary Coronary Intervention for Acute Myocardial Infarction: Results From the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial
Circulation,
September 21, 2004;
110(12):
1598 - 1604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Menon, R. A. Harrington, J. S. Hochman, C. P. Cannon, S. D. Goodman, R. G. Wilcox, H. J. Schunemann, and E. M. Ohman
Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest,
September 1, 2004;
126(3_suppl):
549S - 575S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-I Cheng, K.-H. Yeh, H.-W. Chang, T.-H. Yu, Y.-H. Chen, H.-T. Chai, and H.-K. Yip
Comparison of Baseline Characteristics, Clinical Features, Angiographic Results, and Early Outcomes in Men vs Women With Acute Myocardial Infarction Undergoing Primary Coronary Intervention
Chest,
July 1, 2004;
126(1):
47 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Montalescot, H R Andersen, D Antoniucci, A Betriu, M J de Boer, L Grip, F J Neumann, and M T Rothman
Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction
Heart,
June 1, 2004;
90(6):
e37 - e37.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-K. Yip, C.-Y. Fang, K.-T. Tsai, H.-W. Chang, K.-H. Yeh, M. Fu, and C.-J. Wu
The Potential Impact of Primary Percutaneous Coronary Intervention on Ventricular Septal Rupture Complicating Acute Myocardial Infarction
Chest,
May 1, 2004;
125(5):
1622 - 1628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Przyklenk, G. Li, B. Z. Simkhovich, and R. A. Kloner
Mechanisms of myocardial ischemic preconditioning are age related: PKC-{epsilon} does not play a requisite role in old rabbits
J Appl Physiol,
December 1, 2003;
95(6):
2563 - 2569.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H.-K. Yip, C.-J. Wu, H.-W. Chang, C.-P. Wang, C.-I Cheng, S. Chua, and M.-C. Chen
Cardiac Rupture Complicating Acute Myocardial Infarction in the Direct Percutaneous Coronary Intervention Reperfusion Era
Chest,
August 1, 2003;
124(2):
565 - 571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Thiemann
Primary angioplasty for elderly patients with myocardial infarction: Theory, practice and possibilities
J. Am. Coll. Cardiol.,
June 5, 2002;
39(11):
1729 - 1732.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Osula, G M Bell, and R S Hornung
Acute myocardial infarction in young adults: causes and management
Postgrad. Med. J.,
January 1, 2002;
78(915):
27 - 30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Przyklenk, G. Li, and P. Whittaker
No loss in the in vivo efficacy of ischemic preconditioning in middle-aged and old rabbits
J. Am. Coll. Cardiol.,
November 15, 2001;
38(6):
1741 - 1747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zahn, R. Schiele, S. Schneider, A. K. Gitt, H. Wienbergen, K. Seidl, T. Voigtlander, M. Gottwik, G. Berg, E. Altmann, et al.
Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty?: Results from the pooled data of the maximal individual therapy in acute myocardial infarction registry and the myocardial infarction registry
J. Am. Coll. Cardiol.,
June 1, 2001;
37(7):
1827 - 1835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Verdu-Pascual and A. Castello-Ponce
Randomised clinical trials: a source of ethical dilemmas
J. Med. Ethics,
June 1, 2001;
27(3):
177 - 178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Priebe
The aged cardiovascular risk patient
Br. J. Anaesth.,
November 1, 2000;
85(5):
763 - 778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Braunwald, E. M. Antman, J. W. Beasley, R. M. Califf, M. D. Cheitlin, J. S. Hochman, R. H. Jones, D. Kereiakes, J. Kupersmith, T. N. Levin, et al.
ACC/AHA guidelines for the management of patients with unstable angina and non-st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)
J. Am. Coll. Cardiol.,
September 1, 2000;
36(3):
970 - 1062.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Scheinman
Mechanisms of atrial fibrillation: is a cure at hand?
J. Am. Coll. Cardiol.,
May 1, 2000;
35(6):
1687 - 1692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Age-Independent Benefits of Primary Angioplasty
Journal Watch Cardiology,
March 20, 1999;
1999(320):
6 - 6.
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Napoli, G. Aldini, J. L. Wallace, F. de Nigris, R. Maffei, P. Abete, D. Bonaduce, G. Condorelli, F. Rengo, V. Sica, et al.
Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis
PNAS,
February 5, 2002;
99(3):
1689 - 1694.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|